We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ATP5PF
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • ATP5PF
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

ATP5PF is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 372.65
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 364.6
Number of samples 362
Samples
Sample Description pTPM
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 824.9
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 788.0
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 718.7
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 698.1
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 690.9
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 666.5
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 660.4
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 645.4
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 643.8
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 640.9
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 639.1
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 637.1
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 636.6
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 627.8
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 613.4
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 608.4
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 600.5
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 599.9
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 593.8
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 588.1
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 587.2
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 586.7
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 580.8
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 579.2
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 565.8
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 558.5
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 558.1
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 555.0
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 550.7
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 550.2
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 549.7
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 546.3
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 542.4
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 540.3
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 539.5
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 536.3
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 533.4
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 533.0
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 522.7
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 520.5
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 519.6
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 518.6
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 517.0
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 514.6
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 512.1
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 512.1
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 507.6
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 507.1
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 505.9
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 504.3
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 498.5
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 496.5
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 496.0
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 495.8
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 494.8
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 494.3
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 494.3
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 493.1
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 490.6
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 485.1
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 483.8
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 482.3
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 482.1
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 477.5
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 476.5
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 476.4
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 474.9
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 472.6
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 471.2
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 471.1
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 470.6
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 469.6
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 468.7
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 468.5
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 468.0
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 467.8
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 467.2
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 467.0
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 466.1
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 464.3
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 462.7
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 462.0
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 456.7
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 456.2
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 456.1
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 453.4
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 452.7
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 448.3
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 448.1
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 447.8
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 445.9
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 442.2
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 441.3
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 435.5
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 435.2
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 434.8
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 433.4
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 431.8
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 431.6
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 431.4
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 431.2
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 430.9
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 430.1
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 430.1
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 427.9
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 427.7
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 425.8
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 425.6
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 424.9
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 424.8
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 424.0
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 418.9
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 418.8
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 417.4
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 416.6
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 415.7
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 415.1
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 414.0
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 413.0
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 413.0
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 411.7
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 411.6
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 410.4
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 409.4
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 409.0
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 407.8
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 407.6
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 407.0
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 406.4
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 406.3
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 406.2
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 405.7
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 405.1
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 399.3
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 398.2
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 395.9
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 395.5
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 393.8
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 393.5
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 393.1
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 392.4
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 392.1
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 392.0
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 391.9
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 390.2
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 386.3
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 385.9
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 385.7
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 383.5
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 381.4
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 380.2
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 379.0
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 377.6
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 377.5
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 377.4
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 377.1
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 376.1
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 375.3
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 375.3
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 374.5
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 374.5
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 373.6
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 373.5
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 373.1
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 372.2
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 371.1
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 370.5
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 369.6
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 369.3
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 364.6
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 362.5
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 362.5
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 362.2
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 361.2
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 360.1
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 359.7
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 356.7
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 355.7
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 354.1
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 352.4
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 352.4
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 350.6
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 349.5
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 347.0
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 346.8
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 342.5
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 341.8
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 339.5
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 339.1
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 339.0
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 338.9
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 338.7
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 338.2
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 336.9
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 334.5
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 334.2
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 333.0
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 332.0
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 331.4
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 331.1
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 330.2
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 330.1
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 329.9
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 329.5
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 329.4
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 329.0
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 327.4
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 326.6
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 326.0
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 325.9
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 325.3
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 323.9
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 322.6
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 322.3
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 322.3
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 321.5
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 320.8
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 320.4
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 319.2
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 318.3
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 317.3
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 317.0
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 316.5
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 315.8
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 314.3
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 311.9
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 311.3
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 310.7
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 310.2
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 310.0
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 309.6
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 308.3
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 306.2
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 305.7
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 305.7
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 304.3
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 303.7
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 301.3
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 301.1
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 301.0
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 300.2
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 299.6
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 298.9
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 298.1
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 298.0
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 296.8
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 296.6
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 295.3
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 294.5
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 293.5
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 291.8
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 291.3
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 289.4
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 289.1
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 288.6
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 288.4
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 288.0
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 287.9
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 286.5
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 284.3
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 284.0
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 283.2
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 280.1
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 280.0
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 277.7
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 274.9
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 274.1
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 273.0
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 272.5
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 272.5
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 271.7
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 270.4
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 270.1
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 269.1
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 268.0
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 267.2
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 266.7
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 265.5
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 262.6
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 261.9
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 261.8
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 260.8
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 258.8
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 258.6
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 258.3
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 257.3
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 257.0
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 256.5
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 256.2
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 256.1
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 256.1
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 255.3
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 255.3
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 254.4
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 250.7
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 250.3
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 250.0
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 249.9
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 249.2
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 248.7
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 245.2
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 243.6
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 243.5
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 241.9
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 236.6
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 235.2
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 234.5
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 233.0
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 232.1
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 231.8
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 230.3
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 229.7
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 228.3
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 227.7
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 227.5
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 226.7
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 223.7
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 223.1
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 222.9
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 219.4
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 218.9
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 218.3
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 216.3
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 215.9
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 215.6
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 210.7
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 207.6
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 206.7
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 203.0
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 202.1
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 199.6
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 194.7
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 192.8
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 192.7
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 189.3
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 187.4
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 185.8
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 183.4
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 180.2
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 180.0
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 179.4
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 177.8
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 177.6
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 177.1
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 176.9
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 176.6
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 175.3
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 173.0
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 166.5
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 165.5
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 161.8
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 159.9
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 156.9
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 156.8
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 156.3
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 148.9
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 147.6
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 145.5
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 145.0
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 138.3
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 99.5
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 95.3
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

  Survival analysis data not available.
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
627 Tumor 1.5
513 Tumor 0.9
571 Tumor 0.9
227 Tumor 0.9
714 Normal 0.8
534 Normal 0.8
698 Normal 0.8
922 Normal 0.8
745 Tumor 0.8
756 Normal 0.8
786 Normal 0.7
868 Normal 0.7
722 Normal 0.7
912 Normal 0.7
882 Normal 0.7
448 Normal 0.7
858 Normal 0.7
1045 Tumor 0.7
462 Normal 0.7
824 Normal 0.7
328 Normal 0.7
738 Normal 0.7
964 Normal 0.7
723 Tumor 0.7
862 Normal 0.7
482 Normal 0.7
488 Normal 0.6
1043 Tumor 0.6
546 Normal 0.6
472 Normal 0.6
864 Normal 0.6
514 Normal 0.6
356 Normal 0.6
1032 Normal 0.6
648 Normal 0.6
944 Normal 0.6
515 Tumor 0.6
746 Normal 0.6
852 Normal 0.6
866 Normal 0.6
1027 Tumor 0.6
484 Normal 0.6
412 Normal 0.6
636 Normal 0.5
1014 Normal 0.5
982 Normal 0.5
818 Normal 0.5
1046 Normal 0.5
984 Normal 0.5
528 Normal 0.5
728 Normal 0.5
696 Normal 0.5
938 Normal 0.5
742 Normal 0.5
976 Normal 0.5
564 Normal 0.5
958 Normal 0.5
518 Normal 0.5
1025 Tumor 0.5
572 Normal 0.5
785 Tumor 0.5
286 Normal 0.5
487 Tumor 0.5
823 Tumor 0.5
1022 Normal 0.5
228 Normal 0.5
364 Normal 0.4
926 Normal 0.4
923 Tumor 0.4
954 Normal 0.4
924 Normal 0.4
494 Normal 0.4
481 Tumor 0.4
716 Normal 0.4
1026 Normal 0.4
874 Normal 0.4
128 Normal 0.4
526 Normal 0.4
713 Tumor 0.4
686 Normal 0.4
978 Normal 0.4
878 Normal 0.4
1044 Normal 0.4
1042 Normal 0.4
416 Normal 0.4
918 Normal 0.4
925 Tumor 0.4
436 Normal 0.4
867 Tumor 0.4
968 Normal 0.4
981 Tumor 0.4
1041 Tumor 0.4
916 Normal 0.4
616 Normal 0.4
727 Tumor 0.4
284 Normal 0.3
388 Normal 0.3
914 Normal 0.3
474 Normal 0.3
568 Normal 0.3
538 Normal 0.3
554 Normal 0.3
695 Tumor 0.3
232 Normal 0.3
1028 Normal 0.3
424 Normal 0.3
411 Tumor 0.3
884 Normal 0.3
1016 Normal 0.3
915 Tumor 0.3
1013 Tumor 0.3
537 Tumor 0.3
816 Normal 0.3
478 Normal 0.3
363 Tumor 0.3
628 Normal 0.2
466 Normal 0.2
955 Tumor 0.2
863 Tumor 0.2
212 Normal 0.2
967 Tumor 0.2
423 Tumor 0.2
755 Tumor 0.2
778 Normal 0.2
558 Normal 0.2
911 Tumor 0.2
517 Tumor 0.2
666 Normal 0.2
618 Normal 0.2
524 Normal 0.2
376 Normal 0.2
394 Normal 0.2
553 Tumor 0.2
664 Normal 0.2
516 Normal 0.2
172 Normal 0.2
873 Tumor 0.2
966 Normal 0.2
162 Normal 0.2
298 Normal 0.2
483 Tumor 0.2
142 Normal 0.2
952 Normal 0.2
452 Normal 0.2
461 Tumor 0.2
465 Tumor 0.1
361 Tumor 0.1
414 Normal 0.1
956 Normal 0.1
224 Normal 0.1
257 Tumor 0.1
327 Tumor 0.1
196 Normal 0.1
953 Tumor 0.1
432 Normal 0.1
741 Tumor 0.1
426 Normal 0.1
415 Tumor 0.1
111 Normal 0.1
428 Normal 0.1
662 Normal 0.1
615 Tumor 0.1
392 Normal 0.1
396 Normal 0.1
635 Tumor 0.1
422 Normal 0.1
1031 Tumor 0.1
777 Tumor 0.1
278 Normal 0.0
362 Normal 0.0
314 Normal 0.0
386 Normal 0.0
527 Tumor 0.0
148 Normal 0.0
365 Tumor 0.0
114 Normal 0.0
498 Normal 0.0
344 Normal 0.0
563 Tumor 0.0
214 Normal 0.0
525 Tumor 0.0
393 Tumor 0.0
642 Normal 0.0
352 Normal 0.0
492 Normal 0.0
744 Normal 0.0
921 Tumor 0.0
557 Tumor 0.0
342 Normal 0.0
258 Normal 0.0
721 Tumor 0.0
358 Normal 0.0
446 Normal -0.1
353 Tumor -0.1
332 Normal -0.1
672 Normal -0.1
574 Normal -0.1
477 Tumor -0.1
468 Normal -0.1
186 Normal -0.1
136 Normal -0.1
464 Normal -0.1
218 Normal -0.1
536 Normal -0.1
138 Normal -0.1
222 Normal -0.1
737 Tumor -0.1
857 Tumor -0.1
132 Normal -0.2
861 Tumor -0.2
937 Tumor -0.2
523 Tumor -0.2
137 Tumor -0.2
456 Normal -0.2
366 Normal -0.2
533 Tumor -0.2
354 Normal -0.2
146 Normal -0.2
567 Tumor -0.2
473 Tumor -0.2
617 Tumor -0.2
272 Normal -0.3
1015 Tumor -0.3
126 Normal -0.3
883 Tumor -0.3
957 Tumor -0.3
262 Normal -0.3
431 Tumor -0.3
261 Tumor -0.3
434 Normal -0.3
444 Normal -0.3
368 Normal -0.3
425 Tumor -0.3
697 Tumor -0.3
312 Normal -0.3
443 Tumor -0.3
355 Tumor -0.3
188 Normal -0.3
384 Normal -0.3
223 Tumor -0.3
715 Tumor -0.3
145 Tumor -0.3
743 Tumor -0.4
951 Tumor -0.4
433 Tumor -0.4
451 Tumor -0.4
814 Normal -0.4
913 Tumor -0.4
1021 Tumor -0.4
851 Tumor -0.4
113 Tumor -0.4
685 Tumor -0.4
427 Tumor -0.4
471 Tumor -0.4
268 Normal -0.4
573 Tumor -0.5
491 Tumor -0.5
647 Tumor -0.5
663 Tumor -0.5
977 Tumor -0.5
341 Tumor -0.5
447 Tumor -0.5
983 Tumor -0.5
493 Tumor -0.5
124 Normal -0.5
813 Tumor -0.6
815 Tumor -0.6
975 Tumor -0.6
161 Tumor -0.6
963 Tumor -0.6
187 Tumor -0.6
881 Tumor -0.6
641 Tumor -0.6
285 Tumor -0.6
267 Tumor -0.6
943 Tumor -0.6
127 Tumor -0.6
357 Tumor -0.6
217 Tumor -0.7
135 Tumor -0.7
231 Tumor -0.7
497 Tumor -0.7
297 Tumor -0.7
192 Normal -0.7
375 Tumor -0.7
171 Tumor -0.7
112 Tumor -0.7
435 Tumor -0.7
535 Tumor -0.7
185 Tumor -0.8
313 Tumor -0.8
141 Tumor -0.8
195 Tumor -0.8
191 Tumor -0.8
455 Tumor -0.8
421 Tumor -0.8
665 Tumor -0.8
865 Tumor -0.8
147 Tumor -0.8
917 Tumor -0.8
271 Tumor -0.9
221 Tumor -0.9
367 Tumor -0.9
445 Tumor -0.9
413 Tumor -0.9
387 Tumor -0.9
817 Tumor -0.9
385 Tumor -0.9
383 Tumor -0.9
724 Normal -1.0
213 Tumor -1.0
211 Tumor -1.0
463 Tumor -1.1
311 Tumor -1.1
125 Tumor -1.1
391 Tumor -1.1
131 Tumor -1.1
467 Tumor -1.1
351 Tumor -1.1
661 Tumor -1.1
965 Tumor -1.2
671 Tumor -1.2
277 Tumor -1.2
395 Tumor -1.2
877 Tumor -1.3
545 Tumor -1.4
283 Tumor -1.4
331 Tumor -1.5
343 Tumor -1.5
123 Tumor -1.6
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA031069
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org